Evaluation of artemisinins for the treatment of acute myeloid leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of artemisinins for the treatment of acute myeloid leukemia
Authors
Keywords
Artemisinin, Acute myeloid leukemia, High-throughput screen, Chemotherapy, Cytarabine
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 77, Issue 6, Pages 1231-1243
Publisher
Springer Nature
Online
2016-04-29
DOI
10.1007/s00280-016-3038-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
- (2015) A Eriksson et al. Blood Cancer Journal
- Abstract 818: Repurposing Artemisinins for treatment of acute leukemias
- (2015) Jennifer M. Fox et al. CANCER RESEARCH
- Advances in treatment of de-novo pediatric acute myeloid leukemia
- (2014) Raul C. Ribeiro CURRENT OPINION IN ONCOLOGY
- Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia
- (2013) E. I. Zimmerman et al. BLOOD
- Population Pharmacokinetics of Intramuscular Artesunate in African Children With Severe Malaria: Implications for a Practical Dosing Regimen
- (2013) ICE Hendriksen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- LC–MS/MS method for the simultaneous quantitation of three active components derived from a novel prodrug against schistosome infection
- (2013) Guangzhao He et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Acute myeloid leukaemia in adults
- (2013) Felicetto Ferrara et al. LANCET
- Pharmacokinetics and Pharmacodynamics of Oral Artesunate Monotherapy in Patients with Uncomplicated Plasmodium falciparum Malaria in Western Cambodia
- (2012) David Saunders et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors
- (2012) Mahadeo A. Sukhai et al. JOURNAL OF CLINICAL INVESTIGATION
- Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity
- (2012) Zeng Wang et al. FEBS Open Bio
- Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo
- (2011) Ning Gao et al. APOPTOSIS
- An Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for Ependymoma
- (2011) Jennifer M. Atkinson et al. CANCER CELL
- Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia
- (2011) Shuiying Hu et al. JNCI-Journal of the National Cancer Institute
- Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species
- (2010) Jin-Jian Lu et al. CANCER BIOLOGY & THERAPY
- Heme synthesis increases artemisinin-induced radical formation and cytotoxicity that can be suppressed by superoxide scavengers
- (2010) Shiming Zhang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production
- (2010) Anne Hamacher-Brady et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
- (2009) A. V. Kurtova et al. BLOOD
- Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells
- (2009) Zhaohui Wei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis
- (2008) Ikuhiko Nakase et al. CANCER LETTERS
- Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation
- (2007) Ikuhiko Nakase et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now